Products

Noveltreat 0.5 mg Pre-filled Pen: Optimized Maintenance Therapy for Weight Management Are you looking for a dependable Noveltreat 0.5 mg Pre-filled Pen exporter from India? Ernest Impex, a specialized unit of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global leader in the wholesale distribution of advanced GLP-1 therapies. We offer high-integrity, cold-chain logistics and secure pharmaceutical supply to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Noveltreat 0.5 mg Noveltreat 0.5 mg Pre-filled Pen contains Semaglutide (0.5 mg strength), a revolutionary GLP-1 receptor agonist manufactured by Sun Pharmaceutical Industries Ltd. This specific strength serves as the standard maintenance dose after the initial titration phase, providing enhanced metabolic control for weight loss and blood sugar management. 1. Clinical Indications & Usage Chronic Weight Management: Used for long-term weight reduction in adults with obesity (BMI $ge$ 30 $kg/m^2$) or overweight (BMI $ge$ 27 $kg/m^2$) with weight-related comorbidities. Type 2 Diabetes Control: Indicated as an adjunct to diet and exercise to improve glycemic control (HbA1c) in adults. Adolescent Obesity: Formulated for weight management in pediatric patients aged 12 years and older who meet specific BMI thresholds. Cardiovascular Health: Helps reduce the risk of major adverse cardiovascular events (MACE) like heart attack and stroke in high-risk patients. 2. Mechanism of Action: The Science of Satiety Appetite Suppression: It mimics the GLP-1 hormone, sending signals to the brain to decrease hunger and increase feelings of fullness (satiety). Delayed Gastric Emptying: It slows down the speed at which the stomach empties, resulting in a more gradual rise in blood sugar and longer-lasting satiety. Insulin Stimulation: It triggers the pancreas to release the appropriate amount of insulin in response to food intake. Glucagon Reduction: It inhibits the secretion of glucagon, preventing the liver from releasing unnecessary sugar into the blood. 3. Administration and Dosing Dosage: Administered once weekly on the same day each week. Step-up Therapy: The 0.5 mg dose is typically introduced after the patient has completed the first 4 weeks on the 0.25 mg initiation dose. Technique: Subcutaneous injection in the thigh, abdomen, or upper arm using the user-friendly pre-filled pen system. Storage, Handling, and Stability Protocols Initial Cold-Chain: Store unused pens in a refrigerator between $2^circtext{C}$ In-Use Flexibility: Once the pen is started, it can be kept at room temperature (below $30^circtext{C}$) or refrigerated for up to 56 days. Light Protection: Always keep the pen cap on when not in use to shield the medicine from light. Safety Warning: Do not freeze. Freezing destroys the active molecular structure. If a pen has been frozen, it must be discarded. Documentation & Export Compliance Commercial Invoice & Packing List Certificate of Analysis (COA) Bill of Lading / Airway Bill Regulatory support for TGA, HSA, US-FDA, and MHRA import requirements. PRESCRIPTION MEDICINE IS : YES Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Noveltreat 0.25 mg Pre-filled Pen: Advanced GLP-1 Therapy for Obesity & Metabolic Health Are you seeking a premier Noveltreat 0.25 mg Pre-filled Pen exporter from India? Ernest Impex, an integral division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global leader in the wholesale distribution of high-demand metabolic and endocrine formulations. We provide robust, GDP-compliant supply chains and secure logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Noveltreat 0.25 mg Noveltreat 0.25 mg Pre-filled Pen contains Semaglutide, a breakthrough GLP-1 (Glucagon-Like Peptide-1) receptor agonist manufactured by Sun Pharmaceutical Industries Ltd. It is specifically designed as an initiation therapy to help the body adjust to the medication while effectively managing weight and glycemic levels. 1. Clinical Indications & Usage Management of Obesity: Indicated for long-term weight management in adults and adolescents (12 years and older) with obesity, or overweight adults with at least one weight-related condition (e.g., hypertension, Type 2 diabetes). Cardiovascular Risk Reduction: Helps lower the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or death in adults with established heart disease and high BMI. Type 2 Diabetes Management: Used as an adjunct to diet and exercise to improve blood sugar control in adults. 2. Mechanism of Action: The GLP-1 Pathway Appetite Regulation: It targets receptors in the brain that regulate appetite and satiety, helping patients feel full sooner and reducing intense food cravings. Insulin Modulation: It stimulates the pancreas to release insulin in a glucose-dependent manner (only when blood sugar is high), minimizing hypoglycemic risk. Gastric Emptying: It slows down the rate at which food leaves the stomach, leading to more stable post-meal blood sugar levels. Liver Sugar Control: It reduces the amount of sugar the liver produces and releases into the bloodstream. 3. Administration and Initiation Dose Dosage: The 0.25 mg strength is the starting dose (titration phase), typically administered once weekly for the first 4 weeks. Route: Subcutaneous injection in the abdomen, thigh, or upper arm. User-Friendly Design: The pre-filled pen is designed for easy self-administration after proper training by a healthcare professional. Storage, Handling, and Stability Protocols Primary Storage: Before first use, store the pen in a refrigerator between $2^circtext{C}$ and $8^circtext{C}$.Post-Initiation: After the first injection, the pen can be stored at room temperature (below $30^circtext{C}$) or in the refrigerator for up to 56 days. Protection: Keep the pen cap on when not in use to protect the solution from light.Crucial Safety: Do not freeze. If the Noveltreat pen becomes frozen, it must be discarded immediately. Why Partner with Ernest Impex for Global Sourcing? Verified Supply: We source directly from GMP-certified facilities in India, ensuring 100% genuine products. Specialized Logistics: Expertise in shipping temperature-sensitive (cold-chain) metabolic injections across international borders. Compliance Support: We provide a full documentation suite, including Certificate of Analysis (COA), Commercial Invoice, and export permits for TGA, HSA, and US-FDA/MHRA regions. PRESCRIPTION MEDICINE IS : YES Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Semasize 1 mg Injection: Maximum Maintenance Therapy for Metabolic and Glycemic Health Are you seeking a reliable Semasize 1 mg Injection exporter from India? Ernest Impex, a key member of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global specialist in the wholesale distribution of advanced GLP-1 receptor agonists. We offer streamlined, GDP-compliant logistics and secure supply chains to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Semasize 1 mg Semasize 1 mg Injection contains Semaglutide, a potent metabolic regulator used for the advanced management of Type 2 Diabetes and chronic obesity. As a high-strength maintenance dose, the 1 mg concentration is designed for patients who require more intensive glycemic control or significant weight loss support after completing the initial titration phases (0.25 mg and 0.5 mg). 1. Clinical Indications & Usage Advanced Glycemic Control: Primary treatment for adults with Type 2 Diabetes Mellitus to maintain target HbA1c levels. Intensive Weight Management: Utilized for long-term weight reduction and maintenance in patients with a BMI $ge$ 30 $kg/m^2$ or $ge$ 27 $kg/m^2$ with associated comorbidities MACE Prevention: Proven to significantly reduce the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in high-risk diabetic patients. 2. Mechanism of Action: The GLP-1 Metabolic Engine Dynamic Insulin Secretion: It signals the pancreas to produce the appropriate amount of insulin in response to rising blood sugar levels. Liver Sugar Regulation: It inhibits the liver from producing excess glucose through glucagon suppression. Brain-Gut Axis Modulation: Semasize 1 mg targets the hunger centers in the brain to increase satiety and slow gastric emptying, physically reducing the desire for large caloric intake. Cardiovascular Protection: Beyond glucose, it exerts beneficial effects on blood pressure and lipid profiles. 3. Administration and Dosing Guide Dosing: Injected once weekly on the same day each week. Titration Path: This 1 mg strength is typically reached after at least 8 weeks of treatment (4 weeks at 0.25 mg and 4 weeks at 0.5 mg) to minimize gastrointestinal sensitivity. Route: Subcutaneous injection in the abdomen, thigh, or upper arm. Storage, Handling, and Stability Protocols Initial Storage: Store unused pens in a refrigerator at $2^circtext{C}$ In-Use Period: Once the pen is opened, it can be kept at room temperature (below $30^circtext{C}$) or refrigerated for up to 56 days. Light Protection: Store the pen with the cap on at all times to prevent degradation from UV exposure. Logistics Alert: Do not freeze. If the solution becomes frozen, it must not be used. Documentation & Global Export Compliance Essential Documents: Commercial Invoice, Packing List, Certificate of Analysis (COA), and Bill of Lading. Regulatory Support: We provide necessary paperwork for customs clearance and ensure compliance with TGA, HSA, and FDA/MHRA import guidelines for our regional partners. PRESCRIPTION MEDICINE IS: YES Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Semasize 0.5 mg Injection: Enhanced GLP-1 Therapy for Glycemic Control & Weight Management Are you searching for a trusted Semasize 0.5 mg Injection exporter from India? Ernest Impex, a premier division of the Group of Ernest Pharmaceutical Pvt. Ltd., specializes in the global distribution of high-demand metabolic and endocrine therapies. We provide seamless, GDP-compliant wholesale supply to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Semasize 0.5 mg Semasize 0.5 mg Injection (containing Semaglutide) is a potent GLP-1 receptor agonist designed for the long-term management of Type 2 Diabetes and chronic obesity. Following the initial 0.25 mg titration phase, the 0.5 mg dose serves as a critical maintenance or step-up strength to achieve superior metabolic results. 1. Clinical Indications & Usage Glycemic Optimization: Indicated for adults with Type 2 Diabetes Mellitus to improve HbA1c levels when used alongside diet and exercise. Chronic Weight Management: Effectively utilized for long-term weight reduction in patients with a BMI $ge$ 30 $kg/m^2$ or $ge$ 27 $kg/m^2$ with weight-related comorbidities. Cardiovascular Protection: Clinically proven to reduce the risk of major adverse cardiovascular events (MACE) in adults with Type 2 diabetes and established cardiovascular disease. 2. Mechanism of Action: The Science of Metabolic Control Glucose-Dependent Insulin Secretion: It stimulates the pancreatic beta cells to release insulin only when blood glucose levels are elevated, ensuring effective control without unnecessary hypoglycemic risk. Glucagon Modulation: It suppresses excessive glucagon secretion from the liver, preventing spikes in blood sugar levels between meals. Satiety Induction: By slowing gastric emptying and acting on the brain’s appetite centers (the hypothalamus), it increases feelings of fullness and significantly reduces daily caloric intake. Beta-Cell Preservation: Ongoing research suggests GLP-1 agonists may help preserve pancreatic function over time. 3. Administration & Titration Dosage: The 0.5 mg dose is typically administered once weekly. It is the standard second step in the titration protocol, usually started after 4 weeks on the 0.25 mg dose. Route: Subcutaneous injection in the abdomen, thigh, or upper arm. Storage and Handling Protocols Refrigeration: Unused pens must be stored in a refrigerator at $2^circtext{C}$ In-Use Stability: Once the pen is in use, it can be kept at room temperature (up to $30^circtext{C}$) or in the refrigerator for up to 56 days. Light Sensitivity: Always keep the pen cap on when not in use to protect the medicine from direct sunlight. Cold Chain Management: For bulk export, Ernest Impex ensures strict cold-chain logistics to prevent freezing or overheating, both of which can denature the protein. Documentation & Export Compliance For international bulk orders, Ernest Impex provides a complete documentation suite including a Commercial Invoice, Packing List, Bill of Lading, Certificate of Analysis (COA), and Certificate of Origin. We also facilitate all necessary Customs Clearance and Regulatory Documents to ensure seamless delivery to your destination. PRESCRIPTION MEDICINE IS : YES Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Semasize 0.25 mg Injection: Advanced GLP-1 Therapy for Metabolic Health Are you searching for a trusted Semasize 0.25 mg injection exporter from India? Ernest Impex, a premier division of the Group of Ernest Pharmaceutical Pvt. Ltd., specializes in the global distribution of high-demand metabolic and endocrine therapies. We provide seamless, GDP-compliant wholesale supply to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Semasize 0.25 mg: Semasize 0.25 mg Injection (containing Semaglutide) is a breakthrough GLP-1 receptor agonist primarily used for the management of Type 2 Diabetes and chronic weight management. Produced by leading Indian pharmaceutical manufacturers like Alkem Laboratories, it offers a clinically proven pathway to glycemic control and metabolic optimization. 1. Clinical Indications & Usage: Type 2 Diabetes Mellitus: Indicated as an adjunct to diet and exercise to improve glycemic control in adults. Chronic Weight Management: Used for long-term weight loss in adults with obesity (BMI $ge$ 30 $kg/m^2$) or overweight (BMI $ge$ 27 $kg/m^2$) with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia). Cardiovascular Risk Reduction: Helps lower the risk of major adverse cardiovascular events (MACE) such as heart attack or stroke in patients with established heart disease. 2. Mechanism of Action: The GLP-1 Pathway Insulin Regulation: It stimulates the pancreas to release insulin in a glucose-dependent manner (only when blood sugar is high), minimizing the risk of hypoglycemia. Glucagon Suppression: It reduces the secretion of glucagon, the hormone responsible for releasing stored sugar from the liver. Gastric Emptying: It slows down the rate at which the stomach empties, leading to a more gradual absorption of sugar into the bloodstream. Appetite Control: It targets receptors in the brain (hypothalamus) that regulate appetite and satiety, significantly reducing food cravings and overall caloric intake. 3. Administration & Initiation Dose: Dosage: The 0.25 mg strength is the initiation dose. It is intended to start the treatment for the first 4 weeks to allow the patient's body to adjust to the medication before escalating to higher maintenance doses (0.5 mg, 1 mg, or 2.4 mg). Route: Subcutaneous injection once weekly in the abdomen, thigh, or upper arm. Storage and Handling Protocols: Temperature: Store in a refrigerator between $2^circtext{C}$ and $8^circtext{C}$. Post-First Use: After the first injection, the Semasize pen can be stored at room temperature (below $30^circtext{C}$) or in the refrigerator for up to 56 days.Light Protection: Keep the pen cap on when not in use to protect the solution from light. Do Not Freeze: If the solution becomes frozen, it must be discarded immediately. Safety, Side Effects, and Precautions: Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation. These are usually mild and diminish as the body adjusts to the 0.25 mg dose. Serious Warnings: Risk of thyroid C-cell tumors (avoid if there is a family history of medullary thyroid carcinoma). Monitor for signs of pancreatitis and gallbladder problems. Monitoring: Regular blood glucose monitoring is advised, especially if used in combination with sulfonylureas or insulin. Ernest Impex provides a complete documentation suite, including a Commercial Invoice, Packing List, Bill of Lading, Certificate of Analysis (COA), and Certificate of Origin. We also facilitate all necessary customs clearance and regulatory documents to ensure seamless delivery to your destination. PRESCRIPTION MEDICINE IS : YES Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Tadanova-d: Advanced Dual-Action Therapy for Men’s Health Are you seeking a dependable Tadanova-d Tablet exporter from India? Ernest Impex, an integral division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global leader in the wholesale distribution of specialized men's health and wellness formulations. We provide robust, GDP-compliant supply chains and secure logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Tadanova-d Tablet Tadanova-d Tablet is a premium, fixed-dose combination medication formulated to treat two distinct male sexual health conditions: Erectile Dysfunction (ED) and Premature Ejaculation (PE). Each film-coated tablet combines two active pharmaceutical ingredients: Tadalafil (20 mg) and Dapoxetine (60 mg). 1. Clinical Indications & Usage Erectile Dysfunction: Helps men achieve and maintain a firm, lasting erection by increasing blood flow to the penis during sexual stimulation. Premature Ejaculation: Helps improve control over ejaculation and increases the time until ejaculation, reducing performance anxiety. Support for Psychological Factors: By treating both conditions simultaneously, it helps address psychological stress related to sexual performance. 2. Mechanism of Action: How Tadanova-d Works Tadalafil (PDE5 Inhibitor): Selectively inhibits the phosphodiesterase type 5 (PDE5) enzyme. This action allows for the relaxation of smooth muscles in the corpus cavernosum and increases cGMP levels, resulting in enhanced blood flow and a sustained erection for up to 36 hours. Dapoxetine (SSRI): A short-acting selective serotonin reuptake inhibitor that increases the action of serotonin at the synaptic cleft. This delays the ejaculatory response and gives the patient more control. 3. Administration and Dosing Guide Administration Route: Taken orally with a glass of water, with or without food. Taking it with a meal can help reduce gastrointestinal side effects like nausea.Timing: Administer approximately 1 to 3 hours prior to anticipated sexual activity. Do not exceed more than one dose in a 24-hour period. Precautions: Should not be used by women or individuals with severe cardiovascular, hepatic, or renal impairment. Do not co-administer with nitrates, alpha-blockers, or other potent CYP3A4 inhibitors. Safety, Side Effects, and Monitoring Cardiovascular Monitoring: Use with caution in patients with a history of myocardial infarction, unstable angina, or severe hypotension/hypertension. Common Side Effects: Headache, flushing, dizziness, nausea, and mild diarrhea. Patients should avoid standing up quickly if feeling dizzy. Contraindications: Not approved for women. It is contraindicated in patients with severe liver disease or end-stage kidney disease requiring dialysis. Why Choose Ernest Impex? Traceability: Every shipment is provided with a full Certificate of Analysis (COA) and complete batch traceability. Regulatory Support: We facilitate document clearance and supply chain logistics in compliance with TGA, HSA, and US-FDA/MHRA guidelines. Quality Packaging: Formulations are packed in moisture-resistant Alu-Alu blister packs to strict pharmaceutical standards. Secure Bulk Supply: Consistent inventory availability for institutional healthcare tenders, pharmacies, and specialty clinics. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Yohimbol 5 mg: Advanced Alpha-2 Adrenergic Receptor Antagonist Are you seeking a dependable Yohimbol 5 mg exporter from India? Ernest Impex, an integral division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global leader in the wholesale distribution of specialized therapeutic and wellness formulations. We provide robust, GDP-compliant supply chains and secure logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Yohimbol 5 mg Yohimbol 5 mg contains Yohimbine Hydrochloride, an active alkaloid derived from the bark of the Pausinystalia yohimbe tree. It functions as a highly selective competitive $alpha_2$-adrenergic receptor antagonist. Manufactured to the highest global pharmaceutical standards, it is prescribed and utilized to address metabolic and sexual health needs. 1. Clinical Indications & Usage Lipolysis and Metabolic Support: Used to target stubborn adipose tissue by blocking $alpha_2$-adrenergic receptors, thereby increasing circulating catecholamines and promoting fat metabolism. Sexual Dysfunction Support: Traditionally used to manage erectile dysfunction by stimulating sympathetic drive and increasing localized pelvic blood flow. Sympathomimetic and Energy Support: Acts as an adjuvant to boost metabolic rate and central nervous system activity. 2. Mechanism of Action: How Yohimbol Works $alpha_2$-Adrenergic Receptor Antagonism: It competes for the $alpha_2$-adrenergic receptor binding sites, which normally function as negative feedback regulators that inhibit norepinephrine release. Elevated Norepinephrine Output: By blocking these receptors, the drug increases sympathetic nervous system activity and causes an accumulation of intraneuronal cyclic adenosine monophosphate (cAMP). Enhanced Hemodynamics: The downstream release of catecholamines promotes peripheral vasoconstriction and shunts blood flow while increasing lipolysis. 3. Administration and Dosing Guide Administration Route: Yohimbol 5 mg is taken orally. Dosing is highly individualized and typically starts at 5 mg, taken one to three times daily, to assess tolerance. Peak Plasma Concentration: Reached within 30 to 60 minutes of ingestion. Contraindications & Precautions: Not recommended for patients with severe hypertension, renal failure, or psychiatric conditions due to its stimulatory and sympathomimetic effects. Safety, Side Effects, and Monitoring Cardiovascular Monitoring: May increase heart rate and blood pressure. Continuous monitoring of patients with a history of cardiac conditions is advised. Common Side Effects: Mild anxiety, slight tremors, gastrointestinal discomfort, and increased heart rate. Drug Interactions: Do not co-administer with MAO inhibitors, tricyclic antidepressants, or antihypertensive medication without professional consultation. Why Partner with Ernest Impex for Global Sourcing? Traceability: Every shipment is provided with a full Certificate of Analysis (COA) and complete batch traceability. Regulatory Support: We facilitate document clearance and supply chain logistics in compliance with TGA, HSA, and US-FDA/MHRA guidelines. Quality Packaging: Formulations are packed to strict pharmaceutical standards to prevent moisture, heat, and light degradation. Secure Bulk Supply: Consistent inventory availability for institutional healthcare tenders, pharmacies, and specialty clinics. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Lenmid 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lenmid 5mg? Lenmid 5mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Lenmid is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lenmid Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lenmid prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Lenmid is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Lendomy 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lendomy 5mg? Lendomy 5 mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Lendomy is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lendomy Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lendomy prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Lendomy is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Laviat 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Laviat 5mg? Laviat 5mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Laviat is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Laviat Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Laviat prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Laviat is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Celomide 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Celomide 5mg? Celomide 5 mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Celomide is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Celomide Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Celomide prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Celomide is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict Risk Evaluation and Mitigation Strategy (REMS) or equivalent safety program. Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, UAE, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost-advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Svitinib 12.5mg Capsule (Sunitinib) Detailed Product Information: What is Svitinib 12.5 mg? Svitinib 12.5 mg is an advanced oral oncology medication containing the active pharmaceutical ingredient sunitinib. It belongs to a specialized class of drugs known as tyrosine kinase inhibitors (TKIs). Svitinib is a “multi-targeted“ therapy, meaning it interferes with specific pathways that cancer cells use to grow, divide, and spread throughout the body. The 12.5mg dosage is often utilized for precise dose titration, allowing oncologists to adjust treatment based on patient tolerance and therapeutic response, ensuring a balanced approach to efficacy and safety. Primary Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): A primary treatment for advanced or metastatic kidney cancer. Gastrointestinal Stromal Tumor (GIST): Used for patients with stomach or bowel tumors that have progressed or for those who cannot tolerate other treatments. Pancreatic Neuroendocrine Tumors (pNET): Specifically for progressive, well-differentiated tumors located in the pancreas. Adjuvant Treatment: Helps prevent the recurrence of kidney cancer in high-risk patients following surgical removal of the kidney. Mechanism of Action: How Svitinib Works Signal Inhibition: It blocks the Tyrosine Kinase enzymes found on the surface of cancer cells. These enzymes act as communication signals; by blocking them, Svitinib prevents the “growth“ command from reaching the cell nucleus, halting uncontrolled cell division. Anti-Angiogenesis: It targets VEGF (Vascular Endothelial Growth Factor) and PDGF (Platelet-Derived Growth Factor) receptors. This prevents the tumor from growing new blood vessels. By cutting off these “nutrient supply lines,“ the tumor is starved of oxygen and nutrients. Metastasis Suppression: By disrupting cellular signaling, it inhibits the ability of malignant cells to migrate from the primary site to other organs. Detailed Clinical Instructions Dosage: Always follow the exact dosage and cycle prescribed by your oncologist. The 12.5mg dose is often used for precise titration. Administration: Swallow the capsule whole with water. You may take it with or without food. Integrity: Do not crush, chew, or open the capsule, as this can affect drug absorption and increase the risk of side effects. Consistency: Take your dose at the same time every day to maintain steady blood levels. Cycle Management: Svitinib is frequently taken in cycles (e.g., 4 weeks on, 2 weeks off). Do not skip days unless instructed by a physician. Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels. Potential Side Effects Gastrointestinal: Nausea, diarrhea, vomiting, and mouth sores (stomatitis). Dermatological: Skin discoloration (often a yellowish tint), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles). Cardiovascular: High blood pressure (hypertension). Regular monitoring is essential. Systemic: Fatigue, weakness, and decreased appetite or altered taste (dysgeusia). Hematological: Potential for decreased white blood cell or platelet counts, requiring periodic blood monitoring. Storage and Handling Requirements Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Safety: Keep strictly out of reach of children and pets. Waste Management: Do not dispose of oncology medications in household wastewater. Consult your local pharmacist for proper hazardous waste disposal. Why Choose Ernest Impex? ✔ GMP Quality: We ensure all oncology products meet the highest international manufacturing standards. ✔ Worldwide Strategic Logistics: Expertise in shipping to USA, UK, Thailand, Australia, Singapore, and Jamaica. ✔ Bulk Supply Specialist: A reliable partner for hospital procurement, oncology centers, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Documentation Support: We provide full assistance with COA, invoices, and customs documentation for seamless delivery. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383